-
Je něco špatně v tomto záznamu ?
Some biological actions of PEG-conjugated RNase A oligomers
P Pouckova, J Skvor, G Gotte, F Vottariello, JT Slavik, J Matousek, DV Laurents, M Libonati, J Soucek
Jazyk angličtina Země Slovensko
Typ dokumentu práce podpořená grantem
Grantová podpora
NR8233
MZ0
CEP - Centrální evidence projektů
PubMed
16416018
Knihovny.cz E-zdroje
- MeSH
- antispermatogenní látky farmakologie MeSH
- dimerizace MeSH
- embryo savčí účinky léků MeSH
- lidé MeSH
- melanom experimentální farmakoterapie MeSH
- myši MeSH
- nádorové buněčné linie MeSH
- pankreatická ribonukleasa farmakologie chemie MeSH
- peptidové fragmenty farmakologie chemie MeSH
- polyethylenglykoly farmakologie chemie MeSH
- protinádorové látky farmakologie chemie MeSH
- spermatogeneze účinky léků MeSH
- transplantace nádorů MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- práce podpořená grantem MeSH
Previously we have shown that monomeric RNase A has no significant biological activity, whereas its oligomers (dimer to tetramer) prepared by lyophilizing from 50% acetic acid solutions, show remarkable aspermatogenic and antitumor activities. Furthermore, conjugates prepared by chemical binding of native RNase A to polyethylene glycol (PEG) have shown a significant aspermatogenic and antitumor activities. In this work we show that the chemical conjugation of PEG to the RNase A C-dimer, and to the two RNase A trimers (NC-trimer and C- trimer) decreases the aspermatogenic activity of the oligomers while increasing their inhibitory activity on the growth of the human UB900518 amelanotic melanoma transplanted in athymic nude mice. Moreover, the PEG-conjugated RNaseA oligomers are devoid, like the free oligomers, of any embryotoxic activity.
Institute of Hematology and Blood Transfusion 12820 Prague Czech Republic
Institute of Hematology and Blood Transfusion Prague Czech Republic
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13029615
- 003
- CZ-PrNML
- 005
- 20130916153659.0
- 007
- ta
- 008
- 130916s2006 xo f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)16416018
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Poučková, Pavla, $d 1950- $7 jo2002102951 $u Institute of Hematology and Blood Transfusion, 12820 Prague, Czech Republic.
- 245 10
- $a Some biological actions of PEG-conjugated RNase A oligomers / $c P Pouckova, J Skvor, G Gotte, F Vottariello, JT Slavik, J Matousek, DV Laurents, M Libonati, J Soucek
- 504 __
- $a Literatura
- 520 9_
- $a Previously we have shown that monomeric RNase A has no significant biological activity, whereas its oligomers (dimer to tetramer) prepared by lyophilizing from 50% acetic acid solutions, show remarkable aspermatogenic and antitumor activities. Furthermore, conjugates prepared by chemical binding of native RNase A to polyethylene glycol (PEG) have shown a significant aspermatogenic and antitumor activities. In this work we show that the chemical conjugation of PEG to the RNase A C-dimer, and to the two RNase A trimers (NC-trimer and C- trimer) decreases the aspermatogenic activity of the oligomers while increasing their inhibitory activity on the growth of the human UB900518 amelanotic melanoma transplanted in athymic nude mice. Moreover, the PEG-conjugated RNaseA oligomers are devoid, like the free oligomers, of any embryotoxic activity.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a zvířata $7 D000818
- 650 02
- $a protinádorové látky $x farmakologie $x chemie $7 D000970
- 650 02
- $a antispermatogenní látky $x farmakologie $7 D000988
- 650 02
- $a nádorové buněčné linie $7 D045744
- 650 02
- $a dimerizace $7 D019281
- 650 02
- $a embryo savčí $x účinky léků $7 D004622
- 650 02
- $a lidé $7 D006801
- 650 02
- $a mužské pohlaví $7 D008297
- 650 02
- $a melanom experimentální $x farmakoterapie $7 D008546
- 650 02
- $a myši $7 D051379
- 650 02
- $a transplantace nádorů $7 D009368
- 650 02
- $a peptidové fragmenty $x farmakologie $x chemie $7 D010446
- 650 02
- $a polyethylenglykoly $x farmakologie $x chemie $7 D011092
- 650 02
- $a pankreatická ribonukleasa $x farmakologie $x chemie $7 D012259
- 650 02
- $a spermatogeneze $x účinky léků $7 D013091
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Škvor, Jiří $7 xx0098962 $u Laboratory of Genetics, Department of Anthropology, Faculty of Science of the Charles University, Prague, Czech Republic
- 700 1_
- $a Gotte, G.
- 700 1_
- $a Vottariello, F.
- 700 1_
- $a Slavík, Tomáš $7 xx0139088 $u Institute of Animal Physiology and Genetics, Academy of Science of the Czech Republic, Liběchov, Czech Republic
- 700 1_
- $a Matoušek, Josef, $d 1925- $7 jk01080797 $u Institute of Animal Physiology and Genetics, Academy of Science of the Czech Republic, Liběchov, Czech Republic
- 700 1_
- $a Laurents, D.V.
- 700 1_
- $a Libonati, M.
- 700 1_
- $a Souček, Josef $7 xx0104682 $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 773 0_
- $t Neoplasma $x 0028-2685 $g Roč. 53, č. 1 (2006), s. 79-85 $p Neoplasma $w MED00003470
- 773 0_
- $p Neoplasma $g 53(1):79-85, 2006 $x 0028-2685
- 910 __
- $a ABA008 $b A 1194 $y 3 $z 0
- 990 __
- $a 20130916102855 $b ABA008
- 991 __
- $a 20130916154201 $b ABA008
- 999 __
- $a ok $b bmc $g 993712 $s 828053
- BAS __
- $a 3
- BMC __
- $a 2006 $b 53 $c 1 $d 79-85 $i 0028-2685 $m Neoplasma $x MED00003470
- GRA __
- $a NR8233 $p MZ0
- LZP __
- $a 2013-09/ewbo